UBS Lux Equity Fund Biotech USD vs Avanza Zero

UBS Lux Equity Fund Biotech USD vs Avanza Zero

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

2. Avanza Zero

  • Security

    Avanza Zero

  • Fee

    0.00%

  • ISIN

    SE0001718388

  • Holdings

    25

Fund Holdings

We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with Avanza Zero, we have 33 holdings where Atlas Copco is the largest holding (10.04), followed by Investor (8.02) and Volvo (7.11).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Avanza Zero.

UBS Lux Equity Fund Biotech USD Avanza Zero
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Atlas Copco A
Sweden
10.04 %
2. Moderna Inc
9.21 %
2. Investor B
Sweden
8.02 %
3. Gilead Sciences Inc
USA
4.66 %
3. Volvo B
Sweden
7.11 %
4. BioNTech SE
4.13 %
4. SEB A
Sweden
5.61 %
5. Karuna Therapeutics Inc
3.75 %
5. Assa Abloy B
Sweden
5.42 %
- 6. Hexagon B
Sweden
5.3 %
- 7. Sandvik
Sweden
4.93 %
- 8. Evolution Gaming Group AB
Sweden
4.72 %
- 9. Swedbank A
Sweden
4.31 %
- 10. Atlas Copco B
Sweden
4.05 %
- 11. AstraZeneca
Sweden UK
4 %
- 12. Handelsbanken A
Sweden
3.92 %
- 13. Hennes & Mauritz B
Sweden
3.79 %
- 14. ABB Ltd
Sweden Switzerland
3.61 %
- 15. Ericsson B
Sweden
3.19 %
- 16. Nordea Bank Abp
Finland
3.15 %
- 17. Alfa Laval
Sweden
2.84 %
- 18. Essity B
Sweden
2.81 %
- 19. NIBE Industrier B
Sweden
2 %
- 20. Telia Company AB
Sweden
1.89 %
- 21. SCA B
Sweden
1.62 %
- 22. SKF B
Sweden
1.57 %
- 23. Boliden AB
Sweden
1.36 %
- 24. Tele2 B
Sweden
1.07 %
- 25. Getinge B
Sweden
1.02 %

The list of fund holdings was last updated on September 10, 2025.